In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

EAPCI support to the Women in Innovations (WIN) Initiative

Some concrete actions in return for the initiative...

The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed the WIN initiative during its July 2011 Board meeting.

What WIN stands for?

WIN stands for Women in Innovation, a worldwide initiative chaired by Roxanna Mehran (New York) and Alaide Chieffo (Milan), involving a large number of interventional cardiologists as well as industry members.

WIN Objective

The objective of this group is to improve the cardiovascular management of women by:

  • promoting their enrollment in clinical trials where they are often under-represented,
  • and by enhancing the awareness of the risk of coronary artery disease in women.

Indeed, women are generally well informed of the risk of breast cancer but not sufficiently of the incidence of coronary artery disease.

WIN aims

In order to fulfill its objective, WIN also aims to:

  • support all research and development initiatives set up to improve the therapeutic management of women,
  • and to establish a professional development network dedicated to female interventional cardiologists.

It is a well-known fact that cardiovascular mortality is still abnormally high in women, which amply warrants the development of the WIN initiative.

Outcomes of the endorsement by EAPCI

The endorsement of WIN by EAPCI has been followed by concrete actions:

  • The EAPCI has strongly supported and widely communicated the WINFORSAFETY survey dedicated to interventional cardiologists, nurses and technicians all over Europe.
    The purpose of this survey is to analyze current professional practice with respect to X-ray exposure and to detect potential morbidities associated with interventional cardiology. To date, 551 European cardiologists have completed the survey and we hope that we will receive more than 1,000 replies. Help us to achieve this target by taking part now!

  • Another important action lies in the set-up of registries and especially the TAVI registry, given that women account for half of the patients undergoing TAVI. The members of WIN will be working under the guidance of Prof. di Mario, in order to identify the predictors of complications associated with female gender.
  • The third action involves young interventional cardiologists. The young interventionalist group has recently welcome  young WIN members such as, for instance, Inga Narbute (Riga)
  • The 4th WIN initiative supported by EAPCI is to involve WIN members into all Stent for Life activities in order to increase the general population’s awareness of the risk of heart disease in women.

Among other numerous projects, a  WIN award in recognition of an outstanding initiative is currently being considered. Watch this space!